Here’s whether Viking Therapeutics, Inc (VKTX) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Positives: 50-day MA is rising (+2.10% over 10 days). Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); RSI 19 — oversold. Currently 30.5% off its 52-week high. Score: -3/7.
VKTX is trading below its 200-day MA ($32.76) — a key warning sign the longer-term trend is under pressure. An RSI of 19.4 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +4.8% compares to +27.9% for SPY (trailed the market by 23.0%). The current 30.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $10,484 today
vs. S&P 500 (SPY) — same period trailed market by 23.0%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($32.76)
✗Above 50-day MA ($33.53)
!RSI(14) neutral zone (30–70) — currently 19.4
✓Positive return (+4.8%)
!Within 10% of period high (−30.5%)
Period Range $30.00
$22.96$43.15
RSI (14) 19.4
0 · OversoldOverbought · 100
Key Metrics
Price$30.00
Period Return+4.8%
Period High$43.15
Period Low$22.96
Drawdown−30.5%
MA-50$33.53
MA-200$32.76
RSI (14)19.4
Avg Volume (30d)2.4M
vs. SPYtrailed by 24.2%
Return Rank#681 of 1236
Trend Signals
Price is below the 200-day moving average ($32.76)